Impact of an Evidence‐Based Emergency Department Order Set on Clinical Management of Bell's Palsy Authors: Joyce H Lee, Derek Vos, Margaret Parkhurst, Sara Liu, Dane Genther, Peter Ciolek Published: 2026 ABSTRACT ABSTRACTObjectiveTo assess the impact of an evidence‐based emergency department (ED) order set on the clinical management of patients presenting with Bell's palsy.MethodsThis study included adult patients diagnosed with Bell's palsy in the ED before and after the institution of a new order set, which mirrors the AAO‐HNSF Clinical Practice Guidelines. Data were extracted on demographics, steroid and antiviral prescribing, eye protection, and referrals and analyzed using descriptive statistics.ResultsTwo cohorts of patients diagnosed with Bell's palsy in the ED were compared: those managed prior to the institution of the order set (n = 27, April 2020 to August 2023) and those managed under the new order set (n = 29, September 2023 to November 2025). Demographics were similar across cohorts, with median ages of 50 years in the prior group versus 54 years in the order set group. Use of a tapering steroid regimen increased with the updated order set (79.3% vs. 0%). Eye protection was provided to 89.7% of patients in the updated order set group compared to 85.2% prior. Referrals to otolaryngology increased to 89.7% with the order set compared to 0% prior.ConclusionImplementation of an order set in accordance with the AAO‐HNSF Clinical Practice Guidelines on Bell's palsy improved adherence to best practices, particularly regarding steroid tapers, eye protection, and referral to otolaryngology. These findings suggest that structured ED order sets may enhance the quality and consistency of Bell's palsy care.Level of Evidence3.Keywords: Bell's palsy, emergency department, order set Introduction Bell's palsy is the sudden (maximum severity within less than 72 h) weakness or paralysis of the facial nerve and is considered one of the most common mononeuropathic conditions [1, 2]. A majority of patients recover complete facial function; however, as many as 30% of patients experience incomplete recovery of facial function, which has significant ramifications for patient quality of life [1, 3]. Multiple treatment modalities exist for Bell's palsy, including medical therapy, surgical decompression, and alternative therapy (e.g., acupuncture). Current medical therapy includes antiviral and corticosteroid treatments. A 2016 Cochrane review found corticosteroids to be effective in the treatment of Bell's palsy, defined as the avoidance of incomplete recovery, when compared to placebo or no treatment [4]. A 2019 Cochrane review further found that the addition of antiviral therapy to corticosteroids likely decreased the risk of long‐term sequelae of Bell's palsy; however, the reviewers were unable to draw firm conclusions based on the quality of available evidence [5]. The same study found little to no evidence that antiviral therapy plus corticosteroids affected the rate of incomplete recovery compared to corticosteroids alone [5]. A 2021 update to a Cochrane review found that the current state of evidence did not allow for definitive conclusions on the benefit of early surgical decompression in Bell's palsy compared to non‐surgical management [6]. Treatment also encompasses therapies that are protective against long‐term sequelae of Bell's palsy, such as corneal trauma and dryness due to the patient's inability to move the affected eyelid [2]. Multiple diagnostic modalities exist for Bell's palsy, including imaging and laboratory testing. Evidence is mixed on the utility of these diagnostic modalities. Current guidelines from the American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO‐HNSF) recommend a thorough history and physical examination and prescription of oral steroids with the option of additional oral antiviral therapy. The recommended dosing of oral steroids is either prednisolone 50 mg for 10 days or prednisone 60 mg for 5 days with a 5‐day taper [1]. Current guidelines further recommend eye protection for patients with impaired eye closure [1]. AAO‐HNSF guidelines currently recommend against diagnostic laboratory testing and imaging in patients with Bell's palsy, while electrodiagnostic testing in patients with complete facial paralysis remains up to the discretion of the provider [1]. Finally, patient follow‐up with a facial nerve specialist is also recommended in those with progressive neurologic findings, ocular symptoms, or incomplete facial recovery [1]. While clinical guidelines exist, the degree to which institutions adhere to these guidelines in practice is variable. A retrospective, single‐institution study of 903 patients presenting to the emergency department (ED), primary care, or urgent care found that only 15.5% of patients received treatment in line with AAO‐HNSF clinical guidelines, and only 19.6% received the appropriate dosage of steroids [7]. Proper adherence to therapeutic and diagnostic guidelines may alleviate the medical and economic burdens of incomplete recovery, ophthalmic complications, and unnecessary imaging. Furthermore, the usage of standardized order sets may improve adherence to guideline‐directed management [8, 9, 10, 11]. This study assesses adherence to AAO‐HNSF clinical guidelines for the management of Bell's palsy following the institution of a standardized order set at a single institution in an ED setting. Materials and Methods This is a before‐after observational study conducted at a single institution between April 2020 and November 2025. Patients 18 years of age and older who presented to 15 EDs within a single health system and were ultimately diagnosed with Bell's palsy were included. The study was approved by the Cleveland Clinic Institutional Review Board. An updated ED order set was instituted in September 2023 in accordance with AAO‐HNSF practice guidelines. The updated order set included 60 mg prednisone for 5 days with a 5 day taper, 1 g valacyclovir three times a day for 7 days, and polyvinyl alcohol 1.4% ophthalmic solution. Patients seen before September 1, 2023 were considered part of the cohort managed prior to the institution of the updated order set, while patients seen after were considered part of the cohort managed with the updated order set. Chart review was performed for collection of clinical presentation, treatment, diagnostic imaging, and follow‐up referral details. Incomplete paralysis was defined as partial, rather than complete, loss of facial movement based on ED provider assessment. Descriptive statistical analysis was conducted using R software (R version 4.5.1) [12]. To evaluate the association between the intervention and clinical outcomes, a two‐sided Fisher's exact test was employed. Risk ratios with 95% confidence intervals were calculated using the Miettinen–Nurminen score method, which was selected to provide a more accurate estimate of variability given the small sample sizes. Results A total of 56 adult patients (37.5% female, 62.5% male) diagnosed with Bell's palsy in the ED were included. Two cohorts were compared: those managed prior to the institution of an updated order set (n = 27, “pre‐order set”) and those managed under the updated order set (n = 29). Median follow‐up was 15 days (range, 2–374 days). Baseline demographics were similar across cohorts. The overall cohort had a median age of 52 years. The pre‐order set group median age was 50 years (range, 24–85 years), and the updated orders group median age was 54 years (range, 26–80 years). Race distribution showed that patients were White (n = 38/56, 67.9%), Black (n = 12/56, 21.4%), of multiple races (n = 2/56, 3.6%), or Asian (n = 1/56, 1.8%), with race unavailable for three patients (5.4%). The majority of patients presented with incomplete paralysis in both the updated orders (n = 27/29, 93.1%) and pre‐order set (n = 22/27, 81.5%) groups. Implementation of the order set improved adherence to guideline‐directed management. Steroid therapy was administered to all patients in the updated order set group (n = 29/29, 100.0%), with 79.3% (n = 23/29) receiving the appropriate tapering regimen (Table 1); this was in comparison to 96.3% (n = 26/27) of the pre‐order set receiving steroids (Fisher's exact test, p = 0.482) with none (n = 0/27, 0.0%, p < 0.001) receiving the guideline‐adherent taper (Tables 2 and 3). Antiviral prescribing rates were similar in both groups, with prescription in 93.1% (n = 27/29) of the updated order set group versus 92.6% (n = 25/27) of the pre‐order set group. Eye care measures were provided to 89.7% (n = 26/29) of updated order set patients compared to 85.2% (n = 23/27) in the pre‐order set group (p = 0.700). TABLE 1Steroid treatment regimens in updated order set cohort (N = 29).Treatment regimen N (%)60 mg prednisone with a 5 day taper23 (79.3%)60 mg prednisone daily for 7 days4 (13.8%)50 mg prednisone daily for 5 days1 (3.4%)60 mg prednisone with a 5 day taper and 40 mg prednisone daily for 5 days1 (3.4%) Steroid treatment regimens in updated order set cohort (N = 29). TABLE 2Steroid treatment regimens in pre‐order set cohort (N = 27).Treatment regimen N (%)60 mg prednisone daily for 7 days25 (92.6%)60 mg prednisone daily for 6 days1 (3.7%)No steroids prescribed1 (3.7%) Steroid treatment regimens in pre‐order set cohort (N = 27). TABLE 3Treatment, imaging, and referrals before and after the updated order set.Pre‐order set (%) (n = 27)Updated order set (%) (n = 29) p a RR (95% CI)Steroid therapyYes26 (96.3%)29 (100.0%)0.4821.04 (0.82–1.36)No1 (3.7%)0 (0.0%)Appropriate steroid dosing b Yes0 (0.0%)23 (79.3%)< 0.001NC c No27 (100.0%)6 (20.7%)Any antiviral therapyYes25 (92.6%)27 (93.1%)1.0001.01 (0.77–1.34)No2 (7.4%)2 (6.9%)Antiviral monotherapyYes1 (3.7%)0 (0.0%)0.482NCNo26 (96.3%)29 (100.0%)Eye careYes23 (85.2%)26 (89.7%)0.7001.05 (0.79–1.43)No4 (14.8%)3 (10.3%)Head imagingYes14 (51.9%)15 (51.7%)1.0001.00 (0.61–1.59)No13 (48.1%)14 (48.3%)Referral to FPRS/OTOYes0 (0.0%)26 (89.7%)< 0.001NCNo27 (100.0%)3 (10.3%)Actual follow up with FPRS/OTOYes0 (0.0%)5 (17.2%)0.052NCNo27 (100.0%)24 (82.8%)Resolution of facial palsy among patients with any follow‐upPre‐order set with follow‐up (%) (n = 14)Updated order set with follow‐up (%) (n = 12) p b RR (95% CI)Complete1 (7.1%)4 (33.3%)0.1484.67 (1.73–12.24)Incomplete13 (92.9%)8 (66.7%)Abbreviations: FPRS/OTO: facial plastics and reconstructive surgery/otolaryngology; CI: confidence interval; RR: risk ratio. a Fisher's exact test was used to calculate p value, and a cutoff of p < 0.05 indicates statistical significance. b Appropriate steroid dosing refers to the standardized order set dosing, or 60 mg prednisone for 5 days with a 5‐day taper. c NC: Not calculable; risk ratio is undefined when one group has zero events. Risk ratios are calculated using the Miettinen–Nurminen score method. Treatment, imaging, and referrals before and after the updated order set. Abbreviations: FPRS/OTO: facial plastics and reconstructive surgery/otolaryngology; CI: confidence interval; RR: risk ratio. Fisher's exact test was used to calculate p value, and a cutoff of p < 0.05 indicates statistical significance. Appropriate steroid dosing refers to the standardized order set dosing, or 60 mg prednisone for 5 days with a 5‐day taper. NC: Not calculable; risk ratio is undefined when one group has zero events. Risk ratios are calculated using the Miettinen–Nurminen score method. Imaging was performed in a comparable number of patients across both groups and predominantly consisted of computed tomography (CT) without contrast. Of the updated order set group, 51.7% (n = 15/29) received head imaging, while 51.9% (n = 14/27) of the pre‐order set group received head imaging (p = 1.000). There were no surgical interventions recorded in either cohort. Rates of return to the ED were low, with 3.4% (n = 1/29) of the updated order set group returning for recurrent or persistent Bell's palsy and 14.8% (n = 4/27) of the pre‐order set group returning. Referrals to otolaryngology increased substantially from 0.0% (n = 0/27) in the pre‐order set group to 89.7% (n = 26/29) in the updated order set (p < 0.001). However, only 17.2% (n = 5/29) of patients in the updated order set group eventually saw an otolaryngological provider for follow‐up of their Bell's palsy; this was compared to 0.0% (n = 0/27) of patients in the pre‐order set group seeing an otolaryngological provider (p = 0.052). In the study period, for follow‐up of Bell's palsy diagnosed in the ED, patients in the updated order set group eventually saw neurology (n = 4/29, 13.8%), primary care (n = 9/29, 31.0%), or no provider (n = 17/29, 58.6%). In the pre‐order set group, patients saw ophthalmology (n = 2/27, 7.4%), neurology (n = 8/27, 29.6%), primary care (n = 8/27, 29.6%), or no provider (n = 11/27, 40.7%). Discussion This study demonstrates that implementation of a standardized ED order set improved adherence to AAO‐HNSF clinical practice guidelines for Bell's palsy management. Most notably, the updated order set increased appropriate corticosteroid tapering from 0.0% to 79.3% and otolaryngology referrals from 0.0% to 89.7% while maintaining high rates of antiviral therapy and eye protection measures. The observed improvement in corticosteroid administration with appropriate tapering is clinically significant given the established benefit of corticosteroids in preventing incomplete recovery of facial function [1, 3, 4, 13]. Prior studies have similarly demonstrated that standardized order sets improve patient outcomes in a variety of conditions, though further high‐quality studies are required to confirm this [8, 9, 10, 11]. The near‐universal prescription of steroids in both cohorts (96.3% vs. 100.0%) reflects widespread recognition of their efficacy; however, the lack of guideline‐adherent tapering in the pre‐intervention group suggests knowledge‐practice gaps that standardized order sets can effectively address [14]. Antiviral therapy rates exceeded 90.0% in both groups, despite limited evidence supporting routine combination therapy. While a 2019 Cochrane review suggested antivirals plus corticosteroids may reduce long‐term sequelae, the evidence remains insufficient to mandate their use [5, 15]. This high prescription rate may reflect provider uncertainty or a conservative approach to treatment; AAO‐HNSF guidelines currently deem prescription of combined antiviral and corticosteroid therapy to be via shared decision‐making [1]. The comparable imaging rates across both cohorts (approximately 52.0%) are concerning given AAO‐HNSF recommendations against routine diagnostic imaging in uncomplicated Bell's palsy [1]. This finding suggests that order set implementation alone may be insufficient to modify imaging practices and highlights the need for additional interventions, such as provider education in ruling out alternative diagnoses. The predominant use of CT without contrast likely reflects the ED setting where rapid exclusion of alternative diagnoses may be prioritized, though this approach contributes to unnecessary healthcare costs and radiation exposure [16, 17]. The increase in otolaryngology referrals (0.0% to 89.7%) demonstrates successful implementation of a standardized order set. However, the low actual follow‐up rate with otolaryngology (17.2% in the updated order set group) raises questions about the efficiency of a blanket referral approach. A stepwise follow‐up model embedded in a standardized order set may more closely adhere to AAO‐HNSF clinical practice guidelines [1]. Several limitations should be considered. Given the modest sample size and single‐center design, non‐significant comparisons between cohorts should be interpreted cautiously, as the study may have been underpowered to detect true differences. The before‐after study design cannot fully account for temporal trends or confounding variables that may have influenced practice patterns. Long‐term outcome documentation was markedly incomplete, with resolution status unknown in 58.6% of the updated order set group and 48.1% of the pre‐order set group; this substantially limits any conclusions regarding the effect of the order set on functional recovery, which represents a primary endpoint of guideline‐adherent care. The study period spanned the COVID‐19 pandemic, which may have affected both presentation patterns and follow‐up completion rates [18]. Finally, chart review methodology may underestimate care provided outside the health system. Future directions should focus on interventions to reduce unnecessary imaging, improve specialist follow‐up completion, and enhance outcome documentation. Integration of clinical decision support algorithms at the point of care could address imaging overutilization [19]. Prospective studies with long‐term outcome assessment are needed to determine whether improved guideline adherence translates to better functional recovery and reduced complications. Conclusion In conclusion, standardized order sets represent an effective strategy for improving guideline‐concordant management of Bell's palsy in the ED setting. While medical therapy adherence improved substantially, persistent gaps in imaging utilization and follow‐up completion highlight opportunities for further quality improvement initiatives. Addressing these gaps through multifaceted interventions targeting both provider behavior and system‐level barriers may optimize outcomes for patients with Bell's palsy. Funding The authors have nothing to report. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments We appreciate the Emergency Department providers and patients who made this study possible. AI was used for copy editing purposes, including improving readability and clarity and removing errors in grammar, spelling, and punctuation. Lee J. H., Vos D., Parkhurst M., Liu S., Genther D., and Ciolek P., “Impact of an Evidence‐Based Emergency Department Order Set on Clinical Management of Bell's Palsy,” Laryngoscope Investigative Otolaryngology 11, no. 5 (2026): e70551, 10.1002/lio2.70551. This research was presented at the Triological Society's Combined Sections Meeting on January 23, 2026, in Orlando, FL. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.